To determine the clinical significance and underlying role of Myosin X in LSCC, we made a 2-year follow-up and analyzed the correlations between the expression of Myosin X and lymph node metastasis. This evidence concerns the gene MYO10 and metastatic malignant neoplasm in the lymph nodes.